Skip to content

Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis

Doxycycline and Ceftriaxone in Patients With Suspected Early Lyme Neuroborreliosis and Normal CSF Cell Count.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00942006
Enrollment
200
Registered
2009-07-20
Start date
2009-07-31
Completion date
2011-11-30
Last updated
2009-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected Early Lyme Neuroborreliosis

Keywords

Lyme neuroborreliosis, Lyme borreliosis, erythema migrans, doxycycline treatment, ceftriaxone treatment, outcome, subjective symptoms

Brief summary

The investigators will compare doxycycline and ceftriaxone in treatment of patients with suspected early Lyme neuroborreliosis and normal CSF cell count. The study hypothesis is that the efficacy and adverse effects of both antibiotics are comparable.

Interventions

DRUGdoxycycline

100 mg bid, 14 days

DRUGceftriaxone

2g x 1 iv, 14 days

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>15 years * erythema migrans in 4 months period before neurologic symptoms * normal CSF cell count * absence of more defined clinical symptoms or signs for CNS involvement (radicular pain, meningeal signs, peripheral facial palsy).

Exclusion criteria

* pregnancy * lactation * allergy on doxycycline and ceftriaxone * immune deficiency.

Design outcomes

Primary

MeasureTime frame
Objective sequelae and post-treatment subjective symptoms in patients treated for suspected early Lyme neuroborreliosis with normal CSF cell count with doxycycline or ceftriaxone for 14 days.1 year follow-up

Countries

Slovenia

Contacts

Primary ContactKatarina Ogrinc, MD PhD
katarina.ogrinc1@guest.arnes.si+386 1 522 4217
Backup ContactFranc Strle, PhD MD
franc.strle@kclj.si+386 1 522 2110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026